N-((4'-chloro-3-fluorobiphenyl-4-yl)methyl)piperazine-1-carboxamide

ID: ALA1090397

PubChem CID: 46884034

Max Phase: Preclinical

Molecular Formula: C18H19ClFN3O

Molecular Weight: 347.82

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(NCc1ccc(-c2ccc(Cl)cc2)cc1F)N1CCNCC1

Standard InChI:  InChI=1S/C18H19ClFN3O/c19-16-5-3-13(4-6-16)14-1-2-15(17(20)11-14)12-22-18(24)23-9-7-21-8-10-23/h1-6,11,21H,7-10,12H2,(H,22,24)

Standard InChI Key:  OFDICSWOZIVFQA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
    7.2819    2.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2807    1.4727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9956    1.0598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7120    1.4731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7091    2.3037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9938    2.7128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4221    2.7189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1381    2.3091    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9913    3.5378    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.8510    2.7242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5670    2.3144    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8479    3.5492    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5678    1.4864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2797    1.0766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9950    1.4883    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9939    2.3143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2774    2.7286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5659    1.0607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8534    1.4752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1391    1.0640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1380    0.2381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8572   -0.1748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5686    0.2388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4238   -0.1748    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 10 12  2  0
 11 13  1  0
  6  1  1  0
  1  2  2  0
  5  7  1  0
  3  4  2  0
  7  8  1  0
 11 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
  2 18  1  0
  6  9  1  0
 18 19  2  0
  4  5  1  0
 19 20  1  0
  8 10  1  0
 20 21  2  0
  2  3  1  0
 21 22  1  0
 10 11  1  0
 22 23  2  0
 23 18  1  0
  5  6  2  0
 21 24  1  0
M  END

Associated Targets(Human)

HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.82Molecular Weight (Monoisotopic): 347.1201AlogP: 3.26#Rotatable Bonds: 3
Polar Surface Area: 44.37Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.82CX LogP: 2.89CX LogD: 2.33
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.89Np Likeness Score: -1.77

References

1. Liu KK, Lefker BA, Dombroski MA, Chiang P, Cornelius P, Patterson TA, Zeng Y, Santucci S, Tomlinson E, Gibbons CP, Marala R, Brown JA, Kong JX, Lee E, Werner W, Wenzel Z, Giragossian C, Chen H, Coffey SB..  (2010)  Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity.,  20  (7): [PMID:20202843] [10.1016/j.bmcl.2010.01.107]

Source